600 related articles for article (PubMed ID: 24200282)
1. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
4. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
5. Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.
Braeken DC; Rohde GG; Franssen FM; Driessen JH; van Staa TP; Souverein PC; Wouters EF; de Vries F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2425-2432. PubMed ID: 28860737
[TBL] [Abstract][Full Text] [Related]
6. The natural history of community-acquired pneumonia in COPD patients: a population database analysis.
Müllerova H; Chigbo C; Hagan GW; Woodhead MA; Miravitlles M; Davis KJ; Wedzicha JA
Respir Med; 2012 Aug; 106(8):1124-33. PubMed ID: 22621820
[TBL] [Abstract][Full Text] [Related]
7. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
[TBL] [Abstract][Full Text] [Related]
8. The role of tuberculosis in COPD.
Yakar HI; Gunen H; Pehlivan E; Aydogan S
Int J Chron Obstruct Pulmon Dis; 2017; 12():323-329. PubMed ID: 28176901
[TBL] [Abstract][Full Text] [Related]
9. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
Andréjak C; Nielsen R; Thomsen VØ; Duhaut P; Sørensen HT; Thomsen RW
Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
11. The association between combined non-cystic fibrosis bronchiectasis and lung cancer in patients with chronic obstructive lung disease.
Kim YW; Jin KN; Heo EY; Park SS; Chung HS; Kim DK
Int J Chron Obstruct Pulmon Dis; 2015; 10():873-9. PubMed ID: 26005340
[TBL] [Abstract][Full Text] [Related]
12. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
[TBL] [Abstract][Full Text] [Related]
13. The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery.
Sekine Y; Sakairi Y; Yoshino M; Koh E; Hata A; Suzuki H; Yoshino I
Thorac Cardiovasc Surg; 2014 Jun; 62(4):332-7. PubMed ID: 24879070
[TBL] [Abstract][Full Text] [Related]
14. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
Ohrlander T; Dencker M; Acosta S
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study.
Nishida Y; Takahashi Y; Tezuka K; Yamazaki K; Yada Y; Nakayama T; Asai S
Int J Chron Obstruct Pulmon Dis; 2017; 12():2363-2371. PubMed ID: 28848337
[TBL] [Abstract][Full Text] [Related]
16. Inhaled drugs as risk factors for community-acquired pneumonia.
Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
Eur Respir J; 2010 Nov; 36(5):1080-7. PubMed ID: 20525710
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
18. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.
Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF
Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613
[TBL] [Abstract][Full Text] [Related]
19. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
[TBL] [Abstract][Full Text] [Related]
20. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
